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Background. Renal-specific oxidoreductase (RSOR) has
been recently identified in mice kidneys of diabetic animals,
and it is developmentally regulated. Its expression during fetal,
neonatal, and postnatal periods was assessed under high glucose
ambience.
Methods. Whole-mount immunofluorescence and confocal
microscopy were performed to assess the effect of high glu-
cose on the morphogenesis of mice fetal kidneys. RSOR mRNA
and protein expression was assessed by competitive polymerase
chain reaction (PCR) and immunoprecipitation methods in em-
bryonic kidneys (day E13 to E17) subjected to high glucose
ambience and by Northern and Western blot analyses of kid-
neys of newborn and 1-week-old mice with hyperglycemia. The
spatiotemporal changes in the RSOR expression were assessed
by in situ hybridization analyses and immunofluorescence mi-
croscopy. In addition, the extent of apoptosis in the kidneys was
determined by terminal deoxynucleotidyl transferase (TdT)-
mediated deoxyuridine triphosphate (dUTP) nick-end labeling
(TUNEL) assay.
Results. Whole-mount microscopy of the embryonic
metanephroi revealed a dose-dependent disruption in the
ureteric bud iterations with reduced population of the nascent
nephrons. Both gene and protein expressions were reduced in
day E13 to E17 metanephroi, while increased in kidneys of new-
born and 1-week-old mice. In day E13 and day E15 kidneys, the
RSOR was expressed in the ureteric bud branches and some
of the immature tubules, and its expression was reduced with
high glucose treatment. In day E17 kidneys the RSOR was ex-
pressed in the tubules of the deeper cortex, and its expression
was marginally decreased. In newborn kidneys, this enzyme was
expressed in the subcortical tubules and it spread to the entire
width of the renal cortex in hyperglycemic state. In 1-week-old
mice kidneys, the RSOR was localized to the entire cortex, and
in animals with blood glucose above 300 mg/dL, its intensity in-
creased with extension of expression into the outer medullary
tubules. A dose-dependent fulminant apoptosis was observed
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in day E13 to E17 kidneys subjected to high glucose ambience.
In newborn and 1-week-old mice control kidneys, the apoptosis
was minimal although slightly increased during hyperglycemia.
Conclusion. High glucose has a differential effect on the
RSOR expression in kidneys during the embryonic versus
neonatal/postnatal period. This may partly be related to the
differential degree of apoptosis, a process reflective of oxidant
stress that is seen in diabetic milieu, which as previously has
been shown to adversely effect the modulators of fetal develop-
ment and thereby the morphogenesis of the kidney and RSOR
expression.
Diabetic mellitus is a common metabolic disorder that
is characterized by a hyperglycemic state, which appar-
ently seems to adversely affect the homeostasis of a
wide variety of organs, including the kidney [1, 2]. A
typical kidney lesion is made up of glomerular nod-
ules which evolve with the hypertrophy/hyperplasia of
mesangial cells, increased extracellular matrix (ECM)
and thickening of the glomerular basement membrane
(GBM). Such renal changes are believed to be related
to the increased flux of glucose intermediaries into var-
ious cellular metabolic pathways [3, 4], de novo synthe-
sis of intracellular and extracellular advanced glycation
end products (AGEs) [5, 6], activation of protein ki-
nase C (PKC) [7, 8], increased expression of transforming
growth factor-b (TGF-b) [9–11], increased activity guani-
nine triphosphate (GTP) binding and cell cycle proteins
and their inhibitors [8, 12, 13], and finally generation of
a wide variety of reactive oxygen species (ROS) [14–16]
that induce apoptosis and adversely affect various cel-
lular functions and damage ECM proteins [17, 18]. The
majority of the above pathogenetic mechanisms relating
to the derangement in the intracellular events in diabetic
nephropathy have been worked out in glomerular cells,
and the information in regard to the changes in tubu-
lar cells or in the tubulointerstitium is limited [18–20].
Recently, by subtractive suppression hybridization poly-
merase chain reaction (PCR), a procedure based on se-
lective amplification of differentially expressed genes in
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response to a given experimental stimulus, a tubular en-
zyme was identified in diabetic mice, and it was desig-
nated as renal-specific oxidoreductase (RSOR).
The RSOR is a ∼32 kD cytosolic protein that is ex-
pressed in the tubules. It has an AKR-3 motif near the
N-terminus with high affinity binding for nicotinamide
adenine dinucleotide phosphate (NADPH) [21]. In view
of these properties, it was labeled as an oxidoreductase,
and is also known as aldehyde reductase–like-6 (Aldrl-6).
The RSOR is only expressed in the kidney and it was
found to be developmentally regulated as well [22]. Con-
ceivably, it also plays a role in the morphogenesis of the
kidney, especially of the tubulogenesis in a mouse organ
culture system [23]. However, an in vivo confirmation is
needed before it can be considered to play a definitive
role in metanephrogenesis. The latter commences with
the intercalation of ureteric epithelial bud into the mes-
enchyme; as a result, there is a phenotypic induction in
which mesenchymal cells acquire properties of epithelial
cells which form a condensate around the tips of ureteric
bud branches [24–26]. The condensate later on matures to
form a S-shaped body, the proximal convolution of which
differentiates into a glomerulus after undergoing vascu-
logenesis/angiogenesis [27], while distal convolution de-
velops into various tubular segments of the nephron that
become contiguous with the collecting ducts arising from
the ureteric bud branches. These developmental pro-
cesses are regulated by diverse set of macromolecules,
including ECM proteins and their receptors, integrins
[28]. The ECM molecules that play a morphogenetic
role include various forms of collagens, laminins, and
proteoglycans [29]. The latter are highly susceptible to
oxidative injury that may be generated in various patho-
biologic processes, including diabetic nephropathy [30].
Since the high glucose ambience affects the known mor-
phogenetic modulators (i.e., the proteoglycans) [31], one
would thus expect certain perturbation in renal glomeru-
logenesis and tubulogenesis during embryonic develop-
ment. Since, RSOR has been shown to be up-regulated
in mature animals [21] with hyperglycemia and is devel-
opmentally regulated [22], the question that needs to be
addressed is whether or not its expression is modulated
by high glucose environment during mouse embryonic
development. With this premise, both gene and protein
expression of RSOR was investigated during fetal, neona-
tal, and postnatal periods in this investigation along with
in situ assessment of the extent of apoptosis, a process
reflective of the oxidant stress in high glucose ambience.
METHODS
Animals
Paired male:female mating of 3-month-old ICR mice
(Harlan Co., Indianapolis, IN, USA) was carried out, and
appearance of the vaginal plug was designated as day 0
of the fetal gestation. Mouse fetuses at embryonic day
13 (E13), 15 (E15), 17 (E17), and 19 (E19) of gestation
were harvested and their kidneys were isolated. In addi-
tion, kidneys from 1-week-old mice were obtained. The
kidneys from day E19 embryos and newborn exhibit min-
imal morphologic differences and thus the terms newborn
and day 19 are used interchangeably in this investigation.
Metanephric organ culture system
Kidney explants were harvested at day E13 and E15 of
gestation and maintained in an organ culture for 4 days in
a humidified incubator with a mixture of 95% air and 5%
CO2 at 37◦C, the details of culture conditions are included
in our previous publications [22, 32]. Briefly, the culture
medium consisted of equal volumes of Dulbecco’s modi-
fied Eagle’s medium (DMEM) and Ham’s nutrient mix-
ture F-12 (Sigma-Aldrich Chemical Co., St. Louis, MO,
USA) supplemented with transferrin (50 lg/mL), peni-
cillin (100 lg/mL), and streptomycin (100 lg/mL), and
the pH was maintained at 7.4. The medium was devoid
of insulin, serum, selenium, or any other growth factors.
For high glucose ambience, the D-glucose concentration
in the medium was raised from 5 to 20 mmol/L and
30 mmol/L, and the explants were exposed for 4 days and
then processed for morphologic, immunofluorescence,
in situ hybridization, immunoprecipitation, and competi-
tive reverse transcription (RT)-PCR studies. In addition,
the tissues were processed for terminal deoxynucleotidyl
transferase (TdT)-mediated deoxyuridine triphosphate
(dUTP) nick-end labeling (TUNEL) assay (vide infra),
the latter to determine the extent of apoptosis. The ex-
plants exposed to 30 mmol/L L-glucose served as osmotic
control.
Induction of diabetes
On day E13 of gestation, diabetic state was induced
with an intraperitoneal injection of streptozotocin (STZ)
(150 mg/kg of body weight) (Sigma-Aldrich Chemi-
cal Co.) in a citrate buffer at pH 4.6 [21, 33]. Con-
trol mice received citrate buffer only. At day E15 of
gestation, blood glucose was measured using a blood
glucose monitor (Boehringer Mannheim, Inc., Indiana-
polis, IN, USA), and mice with blood glucose levels >250
mg/dL were selected for continuation of their pregnancy.
The embryos at day E17 and E19 (newborn) of con-
trol nondiabetic and diabetic mothers were harvested
and their kidneys isolated, snap-frozen in liquid nitro-
gen, and processed for mRNA expression by competi-
tive RT-PCR, Northern blot, and in situ hybridization
analyses, and for protein expression by Western blot
analyses and by immunofluorescence microscopy. The
kidneys of 1-week-old infant mice from diabetic moth-
ers were also collected and processed for studies indi-
cated above. The diabetic state in 1-week-old animals was
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maintained by an additional injection of STZ with a re-
duced dose of 100 mg/kg body weight at the time of birth.
Morphologic studies
For light microscopy, the metanephric explants from
organ culture and kidneys of newborn and 1-week-
old mice were immersion-fixed in Karnovsky’s parafor-
maldehyde-glutaraldehyde fixative, postfixed in osmium
tetroxide, dehydrated in graded series of ethanols, and
embedded in (EPON; EM Sciences, Hatfield, PA, USA).
One micrometer thick serial sections (∼100) of the en-
tire EPON-embedded metanephric tissue were prepared
and stained with 1% toluidine blue [31, 34]. The sec-
tions across the midplane of metanephric explants which
included the maximum number of ureteric bud itera-
tions were evaluated for their overall size, population of
glomeruli and tubules, and the extent of apoptosis.
For whole-mount immunofluorescence microscopy,
the D-glucose treated day E13 metanephric explants were
immersion-fixed in 4% paraformaldehyde in phosphate-
buffered saline (PBS) (Formafresh) (Fisher Scientific,
Itaska, IL, USA) for 1 hour at 24◦C followed by
rinsing with a PBS washing buffer containing 0.075%
saponin for three times, 5 minutes each. The specimens
were then treated with a blocking buffer containing
50 mmol/L NH4Cl overnight at 4◦C followed by rins-
ing with washing buffer. After two washes with neu-
raminidase buffer (150 mmol/L NaCl/50 mmol/L sodium
acetate, pH 5.5), the explants were incubated with neu-
raminidase (1 U/mL) for 4 hours at 37◦C, followed by 5
minutes rinsing with washing buffer. After neuraminidase
treatment, samples were incubated in a blocking buffer
(1% fish gelatin in washing buffer) for 30 minutes at
24◦C. The samples were stained with fluorescein isoth-
iocyanate (FITC)–conjugated Dolichos biflorus lectin
(Sigma-Aldrich Chemical Co.) and TRITC-conjugated
peanut agglutinin (PNA) lectin (EY Laboratories, San
Mateo, CA, USA) in the blocking buffer with concentra-
tion of 100 lg/mL and 50 lg/mL, respectively. The sam-
ples were incubated at 37◦C for 1 hour followed by three
rinses with washing buffer, 5 minutes each to reduce the
background. The explants were either examined with a
ultraviolet microscope equipped with Epi-illumination or
viewed with Zeiss LSM 510 laser scanning confocal mi-
croscope (LSCM).
Morphometric studies
Morphometric analyses were carried out on whole-
mount metanephroi stained with lectins and subjected to
immunofluorescence microscopy as extensively detailed
in our previous publications [31, 34]. Briefly, cultured
metanephroi were photographed and printed to a final
magnification of ×150. Relative area of the metanephros
was calculated by point counting method. One cm2 grid
mesh was placed over the photographs and intersecting
points encompassing the entire metanephros were enu-
merated. Then, the total number of glomeruli, stained
with PNA, and tips of ureteric bud branches, stained with
D. biflorus lectin, were counted. To assess the status of
branching dysmorphogenesis, distance from the base to
the distal most tips of its ureteric bud branches was mea-
sured. With these parameters (i.e., relative area, num-
ber of glomeruli, and tips of the ureteric bud branches),
glomerular and ureteric bud densities (number/area)
were computed from10 metanephroi per variable and ex-
pressed as mean + SD. Also, individual branch length
(base to the tips) of each ureteric bud iteration was com-
puted and expressed as mean + SD.
Competitive RT-PCR analyses
Total RNA was isolated from ∼50 explants per
variable by the acid guanidinium isothiocyanate-
phenol-chloroform extraction method as described [35].
Extracted RNAs were treated with RNase-free DNase
(Boehringer Mannheim Co.), followed by an ethanol
precipitation. About 10 lg of total RNAs, from each
variable, were subjected to first-strand cDNA synthesis
using Maloney murine leukemia virus-reverse transcrip-
tase (MMLV-RT) and oligo(dT)25 as a primer. The cDNA
synthesis was carried out at 37◦C for 1 hour in a buffer
containing 50 mmol/L Tris-HCl (pH 8.3), 7 mmol/L
MgCl2, 40 mmol/L KCl, 10 mmol/L dithiothreitol (DTT),
and 1 mmol/L deoxynucleoside triphosphate (dNTP).
The cDNAs from different variables were suspended in
10 lL of deionized and autoclaved water and stored at
−70◦C until further use. For the analysis of RSOR mRNA
in the D-glucose–treated explants, the respective sense
and antisense primers were 5′-CTG GTG GAC GAA
TCT GAC CCA G-3′ and 5′-GCC ACG GAT AGA
AGG AGT GGA ATC G-3′. For b-actin, the respective
sense and antisense primers were 5′-GAC GAC CAT
GGA GAA GAT CTG G-3′ and 5′-GAG GAT GCG
GCA GTG CGG AT-3′ [22]. Using these primers and
“wild-type” renal cDNA, the expected PCR product sizes
would be 430 bp for RSOR and 461 bp for b-actin, re-
spectively. A competitive “mutant” DNA construct con-
taining RSOR sequences was synthesized by inserting
these sense and antisense primers in the “minigene” con-
struct. The latter construct, containing sequences of vari-
ous other genes, is available in our laboratory (GenBank
accession #U17140) [22]. Using these primers, the ex-
pected size of the competitive RSOR and b-actin PCR
products would be 221 and 224 bp, respectively. This mod-
ified minigene construct was used for the mRNA analyses
of the RSOR and b-actin served as a control in these RT-
PCR studies.
For quantitative RT-PCR analyses, a fixed amount
(1 lL) from D- and L-glucose–treated metanephroi and
serial logarithmic dilutions of the competitive template
DNA (0.5 lg/lL) of RSOR and b-actin cDNAs were
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coamplified [22, 32, 33]. The reaction mixture included
5 lL of 10× PCR buffer, 250 lmol/L of each dNTPs,
10 lmol/L of sense and antisense primers and 2.5 U Taq
polymerase (Perkin-Elmer Corp., Boston, MA, USA) in
a total volume of 50 lL. The amplification reaction was
carried out for a total of 30 cycles in a DNA Thermal
Cycler (Perkin-Elmer Corp.). Each cycle consisted of de-
naturation at 94◦C for 1 minute, annealing at 58◦C for 1
minute, and extension at 68◦C for 1 minute. The PCR
products of wild-type and mutant RSOR and b-actin
were analyzed by 2% agarose gel electrophoresis and
photographed using an instant positive/negative film (Po-
laroid Corp., Waltham, MA, USA). The negatives were
analyzed by a scanning densitometer (Hoefer Scientific
Instruments, San Francisco, CA, USA), and the relative
area underneath the tracings was computed. The ratios
between the densitometric readings of wild-type and mu-
tant PCR-DNA products were plotted using a logarithmic
scale on the ordinate (y axis) against the logarithmic di-
lutions of the competitive template DNA on the abscissa
(x axis).
Immunoprecipitation studies
The embryonic kidneys, harvested at day E13 and E15
and treated with 5 mmol/L and 20 mmol/L D-glucose
or 30 mmol/L D- or L-glucose, were labeled with [35S]-
methionine (0.25 mCi/mL) for 12 hours prior to the ter-
mination of the culture [33]. They were rinsed with the
culture media. The explants were then lysed in an ex-
traction buffer [50 mmol/L Tris-HCl, pH 7.5, 50 mmol/L
NaCl, 10 mmol/L ethylenediaminetetraacetic acid
(EDTA), 0.2% NaN3, 1% Triton X-100, 0.25 mmol/L
DTT, 10 mmol/L benzamidine-HCl, 10 mmol/L e-amino-
g-caproic acid, and 2 mmol/L phenylmethylsulfonyl flu-
oride (PMSF)] by shaking vigorously for 2 hours at 4◦C.
The extract was centrifuged at 10,000 × g for 30 min-
utes at 4◦C, and the supernatant was saved. The protein
concentration was adjusted to 100 lg/mL. Immunopre-
cipitation was performed by adding 10 lL (10 lg/mL
of lyophilized IgG fraction) of polyclonal anti-RSOR an-
tibody to 0.5 mL (∼5 ×106 dpm) of the supernatant.
The supernatants containing equal amounts of radioac-
tivity (control vs. diabetic) were employed for immuno-
precipitation. The mixture was gently swirled in an
orbital shaker at 4◦C for 15 hours. After addition of 80 lL
of protein-A sepharose 4B (Pharmacia LKB Biotech-
nology, Piscataway, NJ, USA), the antigen-antibody mix-
ture was incubated for 1 hour at 4◦C. The complex was
then microfuged for 10 seconds followed by washing
three times with the extraction buffer. The immunopre-
cipitated complex was dissolved in a sample buffer [4%
sodium dodecyl sulfate (SDS), 150 mmo/L Tris-HCl, pH
6.8, 20% glycerol, 0.1% bromophenol blue, and 10% b-
mercaptoethanol), boiled for 5 minutes, and subjected to
10% SDS-polyacrylamide gel electrophoresis (PAGE).
The gels were fixed in 10% acetic acid and 10% methanol,
treated with 1 mol/L salicylic acid, vacuum dried, and au-
toradiograms prepared.
Northern blot analyses
Total RNA was extracted from kidneys of day E19
(newborn) of gestation and 1-week-old mice as indi-
cated above [36]. Total RNA (∼2 lg) was subjected to
1.5% agarose gel electrophoresis containing 2.2 mol/L
formaldehyde and capillary- transferred to the Hybond
N+ nylon membranes, (Amersham Co., Piscataway, NJ,
USA). After ultraviolet cross-linking the RNA to the
membranes (UV Stratalinker 2400) (Stratagene Co., La
Jolla, CA, USA), prehybridization was carried out at
65◦C for 4 hours in a solution containing 5× standard
sodium citrate (SSC), 5× Denhardt’s, 0.5% SDS, and
100 lg/mL herring sperm DNA. The membranes were
then hybridized with [32P]-deoxycytidimine triphosphate
(dCTP)-labeled (1 × 106 cpm/mL) RSOR cDNA at 65◦C
for 18 hours [22, 32, 35]. The same membranes were also
hybridized with radiolabeled b-actin cDNA. The blots
were washed under high stringency conditions and au-
toradiograms prepared. The integrity of RNAs and their
equal loading in various lanes was monitored by visualiza-
tion of the intact 18S and 28S bands on the nylon mem-
brane stained with 0.05% methylene blue in 0.5 mol/L
sodium acetate.
In situ hybridization
To evaluate the spatiotemporal gene expression of
RSOR in day E13 and E15 embryonic kidneys exposed
to high glucose ambience and in fetal kidneys of day
E17, E19 (newborn), and 1-week-old mice, in situ hy-
bridization was performed as previously described [22,
32]. Briefly, RSOR cDNA, isolated previously [21], was
subcloned into pBlueScript KS(+) at the EcoRI site, and
it was used as a template to generate [35S]-uridine triphos-
phate (UTP)–labeled sense and antisense riboprobes by
employing T7 and T3 RNA polymerase included in the
Riboprobe In Vitro Transcription System kit (Promega,
Madison, WI, USA). The riboprobes were subjected to
limited alkaline hydrolysis to yield polynucleotide frag-
ments with size range of 100 to 150 bp, which were then
purified by ethanol precipitation. The purified riboprobes
were used for hybridizing with tissues sections of kid-
neys harvested from day E13 to E19 embryos, newborn,
and 1-week-old mice. The kidneys were fixed by immer-
sion in 4% phosphate-buffered paraformaldehyde for
3 hours at 4◦C. They were dehydrated in graded series
of ethanols and embedded in paraffin. Three micrometer
thick tissue sections were prepared, and mounted on glass
slides coated with VectabondTM (Vector Laboratories,
Inc., Burlingame, CA, USA). The tissue sections were
deparaffinized, hydrated, treated with 0.2 N HCl, depro-
teinated by proteinase K treatment, and acetylated with
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0.1 mol/L triethanolamine and 0.25% acetic anhydride.
After washing the sections with 2× SSC, they were pre-
hybridized with hybridization solution (50% formamide,
10% dextran sulfate, 1× Denhardt’s solution, 10 mmol/L
Tris-HCl, pH 8.0, 0.3 mol/L NaCl, 1 mmol/L EDTA, and
10 mmol/L DTT) at 55◦C for 4 hours; followed by hy-
bridization with [35S]-UTP–labeled RSOR riboprobes at
55◦C for 15 hours. After hybridization, the tissue sections
were washed successively with 2×, 1×, and 0.5× SSC in
the presence of 1 mmol/L DTT. The sections were de-
hydrated in graded series of ethanols, air-dried, coated
with NTB2 photographic emulsion (Eastman Kodak Co.,
Rochester, NY, USA), and autoradiograms prepared af-
ter 1 to 2 weeks of exposure. The sections were stained
with Mayer’s hematoxylin and eosin solution (Sigma-
Aldrich Chemical Co.) and photographed with a light
microscope equipped with dark-field oblique and transil-
lumination.
Immunofluorescence microscopy
The spatiotemporal protein expression of RSOR
in day E13 and E15 embryonic kidneys exposed to
high glucose ambience and in fetal kidneys of day
E17, E19 (newborn), and 1-week-old mice was de-
termined. The kidneys were snap-frozen in chilled
isopentane and embedded in 22-oxacalcitriol (OCT)
compound (Miles Laboratories, Torrance, CA, USA).
Four micrometer thick cryostat sections were prepared
and air-dried. They were washed with 0.01 mol/L
PBS, pH 7.4, followed by incubation with polyclonal
anti-RSOR antibody for 60 minutes in a humidified
chamber at 24◦C. After rinsing with PBS, sections were
incubated with FITC-conjugated goat antirabbit IgG an-
tibody for 30 minutes. They were rinsed three times with
PBS, and then examined with an ultraviolet light micro-
scope equipped with Epi-illumination.
Apoptosis in embryonic and neonatal kidneys subjected
to high glucose ambience
There is a basal amount of apotopsis that is normally
seen during metanephric development, and conceivably
exposure to glucose accentuates the degree of apoptosis
like seen in cell culture systems [37]. An in situ cell death
detection kit (Boehringer Mannheim Biochemicals) was
employed, in which nicked or blunt ends of DNA strands
or the 3’OH ends of genomic DNA are labeled with flu-
orescein dUTP and the reaction is catalyzed by termi-
nal deoxynucleotidyl transferase (TdT). This procedure is
known as the TUNEL assay. The kidneys were immersion
fixed in 4% phosphate-buffered (pH 7.4) paraformalde-
hyde solution for 3 hours at 24◦C and embedded in paraf-
fin blocks. Four micrometer thick sections were prepared,
mounted on clean glass slides, deparaffinized, and rehy-
drated with decreasing concentrations of ethanols. The
sections were incubated with proteinase K (20 lg/mL in
10 mmol/L Tris-HCl, pH 7.4) for 20 minutes at 37◦C. They
were then rinsed with PBS and processed for TUNEL as-
say by following instructions provided by the vendor. The
tissue sections were then examined with an ultraviolet mi-
croscope equipped with Epi-illumination. Appropriate
positive (DNase-digested) and negative (TdT-untreated)
controls were also included during the TUNEL reaction.
RESULTS
The effect of high glucose ambience on the light mi-
croscopy of metanephric explants harvested day E13 of
gestation has been detailed in our previous publication
[22, 31–33], thus they are briefly described in the section
of apoptosis, and here only the findings of whole-mount
immunfluorescence microscopy are included.
Effect of high glucose ambience on whole-mount
morphology of the metanephros
In general, the size of metanephroi exposed to high
glucose ambience was notably reduced, and the in-
trinsic changes are elucidated by staining with vari-
ous lectins. The FITC-conjugated D. biflorus lectin and
TRITC-conjugated PNA were used as the markers of
ureteric bud branches and glomeruli, respectively. A
highly intricate network of dichotomous branches of
the metanephric ureteric bud was seen by immunoflu-
orescence microscopy (Fig. 1A). The ureteric bud iter-
ations were swollen and reduced with the exposure of
30 mmol/L D-glucose (Fig. 1B, arrows). In addition, the
tips of the ureteric branches were flattened, and they
seem to be blunted. Similar alterations were noted when
whole mount metanphroi, exposed to high glucose am-
bience, were examined by confocal microscopy (Fig. 1C
to J). The changes were discernible at 20 mmol/L of D-
glucose, where mild swelling of ureteric branches (Fig. 1C
vs. E) with reduced population of glomeruli was observed
(Fig. 1D vs. F, arrowheads). The reduction in the popu-
lation relative to the changes in the ureteric bud itera-
tions was easily noticed in images of metanephroi stained
with FITC and TRITC were superimposed (Fig. 1G vs.
H). The changes were readily visualized in metanephroi
that were treated with 30 mmol/L D-glucose and exam-
ined by confocal microscopy (Fig. 1I vs. J). At this con-
centration, there was a notable decrease in size of the
metanephroi, as reflected by ∼30% reduction in the sur-
face area (Table 1). Also, the reduction of the ureteric
bud iterations with blunting of the tips and in the popu-
lation of the glomeruli was highly accentuated, implying
that the changes in tips may interfere in their intercala-
tion into the embryonic metanephric mesenchyme and
epithelial:mesenchymal interactions leading to the loss
of generation of nascent nephrons. Quantitative analy-
ses confirmed that there was a notable decrease in the
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Fig. 1. Effect of high glucose ambience on the morphology of the em-
bryonic day E13 metanephric explants, as assessed by whole mount im-
munofluoresecnce (A and B) and confocal microscopy (C to J). The D-
glucose–treated explants were stained with fluorescein isothiocyanate
(FITC)–conjugated Dolichos biflorus and TRITC-conjugated peanut
agglutinin lectin to mark the ureteric bud iterations and glomeruli, re-
spectively. In controls (5 mmol/L), a highly intricate network of dichoto-
mous branching of the ureteric bud is seen (A, C, G, and I). With the
high glucose treatment (20 to 30 mmol/L) a dose-dependent reduction
in the dichotomous iterations with swelling and blunting of the tips of
the ureteric bud branches is observed (B, E, H, and J). Along with the
changes in the ureteric bud branching (B vs, A, arrows), a reduction in
the population of glomeruli is observed (F vs. D, arrowheads).
glomerular and tip densities (number/area) as much as
by ∼30% (Table 1). In addition, the length of the ureteric
bud branches (base to the tips) was reduced by ∼50%
in metanephroi treated with 30 mmol/L D-glucose com-
pared to the control (414.3 ± 93.64 lm vs. 755.6 ±
144.79 lm).
Gene expression in embryonic and neonatal kidneys of
fetuses and mice subjected to high glucose ambience
Competitive RT-PCR analyses were performed on day
E13 and E15 metanephroi exposed to high glucose, and
day E17 embryonic kidneys harvested from mice hav-
ing maternal diabetes induced with the administration
of STZ. The RT-PCR analyses deemed necessary since
the metanephroi are quite small and large number of ex-
plants (>100) per variable are required to isolate suf-
ficient RNA to assess the expression by Northern blot
analysis. In the control (5 mmol/L glucose or 30 mmol/L
L-glucose–treated explants), a linearity in the ratios of
wild to mutant RSOR DNA could be maintained when
plotted against the 10−2 to 10−7 serial logarithmic dilu-
tions of the competitive (mutant) template DNA. Within
this range of dilutions, the bands of wild-type and mu-
tant DNA were discernible for densitometric analyses to
obtain a ratio. The densitometric graphic plots are not
included here since they have been extensively detailed
in previous publications for other genes [22, 32, 33], and
thus only the raw data (i.e., electrophoretograms) are in-
cluded (Fig. 2A). In the day E13 metanephroi exposed to
5 mmol/L D-glucose (control group), a ratio of ∼1 was ob-
tained at dilution of 10−3 of the competitive mutant DNA
[Fig. 2A (a), double-headed arrow]. In the experimental
group (30 mmol/L D-glucose–treated explants), a ratio of
∼1 was obtained at a dilution of 10−5 of the competitive
DNA [Fig. 2A (b), double-headed arrow]. This suggests
a decrease in the order of about two logs of mRNA ex-
pression in the high D-glucose–treated explants. In the
day E15 metanephroi treated with 5 mmol/L D-glucose,
a ratio of ∼1 was obtained at dilutions of 10−3 to 10−4
of the competitive mutant DNA [Fig. 2A (e)], and those
exposed to high glucose ambience, a ratio of ∼1 was ob-
tained at dilutions of 10−4−10−5 of the competitive DNA
[Fig. 2A (f)], suggesting a decrease in the order of about
a log of mRNA expression. Similarly, for day E17 embry-
onic metanephroi, harvested from diabetic mothers, the
ratio of one shifted from 10−3 to 10−4 to 10−5−10−6 of the
competitive mutant DNA [Fig. 2A (i) vs. (j)], indicating
about two logs decrease in the mRNA expression. How-
ever, for b-actin, no significant differences in the linearity
relationship in the range of logarithmic dilutions of the
competitive DNA between the two groups (b-actin con-
trol and high D-glucose) were observed. The ratio of ∼1
varied from dilutions of 10−3 to 10−5 of the competitive
mutant DNA among day E13, E15, and E17 metanephroi,
however, there was no change in high D-glucose-treated
or hyperglycemic groups compared to the control [Fig. 2A
(c) vs. (d), (g) vs. (h), and (k) vs. (l)].
Northern blot analyses of mRNA isolated from kid-
neys of control (CON) newborn mice with blood glu-
cose of ∼110 mg/dL revealed a single RSOR transcript
of ∼1.5 kb (Fig. 2B, arrow, lane 1). The mRNA expres-
sion in the newborn mice kidneys was elevated with
increasing blood glucose levels in diabetic animals, as re-
flected by the increased intensity of the transcript bands.
Clearly, the intensity of the transcript band in mice with
above 300 mg/dL blood glucose was accentuated (Fig. 2B,
lane 3). At 1-week, a single transcript was noted, and no
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Table 1. Number of glomeruli and tips of ureteric bud branches per unit area of the metanephroia exposed to normal (5 mmol/L) and high (30
mmol/L) glucose ambience in an organ culture
Glomeruli Tips of ureteric bud branchesb
D-glucose Number Area Number/area Number Area Number/area
5 mmol/L 70.60 ± 3.34 301.3 ± 16.50 0.231 ± 0.015 60.90 ± 3.60 299.3 ± 14.84 0.201 ± 0.001
30 mmol/L 33.40 ± 3.77c 205.2 ± 10.02d 0.163 ± 0.017e 27.30 ± 2.49c 199.5 ± 11.77d 0.135 ± 0.009e
aN = 10, number of metanephroi examined in each group. The data are given as mean ± SD.
bThe length of ureteric bud branches (base to the tips) was also reduced between the two groups (755.6 ± 144.792 lm vs. 414.3 ± 93.645 lm) (P < 0.01).
c,d,e Statistically significant differences (P < 0.01) between control (5 mmol/L) and high (30 mmol/L) glucose groups.
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Fig. 2. Analyses of renal-specific oxidoreductase (RSOR). (A) Competitive reverse transcription-polymerase chain reaction (RT-PCR) analyses
of RSOR [(a), (b), (e), (f), (i), and (j)] and b-actin [(c), (d), (g), (h), (k), and (l)] cDNAs, prepared from control (5 mmol/L D-glucose) [(a), (c), (e),
and (g)], embryonic day E13 and E15 metanephroi treated with 30 mmol/L D-glucose [(b), (d), (f), and (h)], day E17 fetal kidneys of normoglycemic
mothers [(i) and (k)] and of hyperglycemic mice [(j) and (l)]. In the RSOR control at day E13 [(a)], a ratio of ∼1 is obtained at dilution of 10−3
of the competitive mutant DNA (double-headed arrow). In the experimental group [(b)], a ratio of ∼1 is obtained at a dilution of 10−5 of the
competitive DNA (double-headed arrow), suggesting a decrease in the mRNA expression. For b-actin, no change in the ratio of ∼1 is observed
between the two groups is seen [(c) vs. (d)]. In the day E15 control metanephroi [(e)], a ratio of ∼1 is obtained at a dilution range of 10−3 to 10−4
(double-headed arrow) and it shifted to 10−4to 10−5 of the competitive DNA [(f), double-headed arrow]. No change in the ratio is observed for
b-actin [(g) vs. (h)]. For day E17 embryonic metanephroi, harvested from diabetic mothers, a ratio of ∼1 shifted from 10−3 to 19−4 to 10−5 to 10−6
of the competitive mutant DNA compared to those from normoglycemic mothers [(i) vs. (j), double-headed arrows), and no significant change in
the b-actin expression is observed [(k) vs. (l), double-headed arrows). (B and C) Northern blot analyses of mRNA isolated from kidneys of control
(CON) newborn and 1-week-old mice with normoglycemia and diabetes mellitus (DM). A single RSOR transcript of ∼1.5 kb is observed (arrow).
The mRNA expression in kidneys of both newborn and 1-week-old mice increases in proportion with the increasing blood glucose levels in diabetic
animals (DM), as reflected by the increased intensity of the transcript bands.
isoforms related to alternate splicing were observed in
mice with normoglycemia (Fig. 2C, lane 1). Like in the
newborn, the 1-week-old mice with hyperglycemia had
increasing intensity of the transcript bands that were pro-
portionate to the blood glucose levels (Fig. 2C, lanes 2
and 3), suggesting that RSOR mRNA is modulated by
the high glucose levels during the post-natal life. The b-
actin expression in mouse kidneys was constant during
the entire postnatal period, and it was unaltered in mice
with hyperglycemic state (Fig. 2B and C).
Spatiotemporal developmental mRNA expression of
RSOR in embryonic and neonatal kidneys
To confirm the developmental mRNA expression and
to delineate the spatiotemporal distribution of RSOR
during the embryonic and neonatal period and the
changes that occur under high glucose ambience, in situ
hybridization studies were performed. At day E13, a
mild mRNA expression of RSOR was observed, which
seemed to be localized mainly to the metanephric ureteric
bud branches (Fig. 3A). No signal was noted in the
metanephric mesenchyme. Treatment of day E13 em-
bryonic explants with 30 mmol/L D-glucose for 96 hours
caused a notable reduction in the size of the metanephroi,
and RSOR mRNA expression was not discernible in
the ureteric bud branches (Fig. 3B). At day E15, the
RSOR mRNA expression was relatively increased com-
pared to day E13, but still remained confined to the
ureteric bud branches (Fig. 3C). Like the day E13 ex-
plants, treatment of day E15 metanephroi with high glu-
cose caused a reduction in the size and RSOR expression
in the ureteric bud iterations (Fig. 3D). At day E17
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Fig. 3. Spatiotemporal renal-specific oxidoreductase (RSOR) mRNA
expression, as assessed by in situ autoradiography, in embryonic kidneys
(day E13 and E15) treated with D-glucose, and day E17, newborn, and 1-
week-old mice kidneys harvested from normoglycemic/hyperglycemic
mothers. In the control (5 mmol/L) at day E13, the expression of RSOR
is localized to the ureteric bud branches (U) (A). The expression
becomes almost undetectable with the 30 mmol/L D-glucose treatment
(B). At day E15, a relative increase in the expression is seen in the
ureteric bud branches (C), and it is notably reduced with high glucose
treatment (D). At day E17 metanephroi of mouse fetuses of normo-
glycemic mothers, the expression is seen confined to the tubules of
metanephroi, harvested from mouse fetuses of nondi-
abetic mothers, RSOR mRNA expression abruptly in-
creased and was confined to the deeper cortical tubules
and no expression was seen in the medulla (Fig. 3E).
The embryonic kidneys harvested from fetuses of dia-
betic mothers revealed a mild reduction in the RSOR
expression, and it was confined to the deeper cortical
tubules only (Fig. 3F). In addition, a very mild reduc-
tion in the size of the kidneys was observed, suggesting a
marginal effect of high glucose ambience at this stage of
embryonic development. In the day E19 or newborn kid-
neys, the RSOR expression was increased and it spread
across the cortex but was still confined to the subcortical
tubules (Fig. 3G and I). Interestingly, the RSOR expres-
sion was seen in the entire thickness of the renal cortex
in the kidneys harvested from fetuses of diabetic moth-
ers (Fig. 3H and J, double-headed arrow). No expres-
sion was observed in the medulla, and the kidneys were
slightly larger. The kidneys of 1-week-old mice revealed
mRNA expression confined to entire thickness of the
cortex, however, no glomerular or medullary expression
was observed (Fig. 3K). The kidneys of the 1-week-old
neonatal diabetic mice were somewhat larger, and there
was a marked increase in the intensity of RSOR expres-
sion (Fig. 3L). The glomerular and medullary expression,
however, remained absent, suggesting that spatiotempo-
ral changes in the RSOR mRNA expression are confined
to the cortical tubules only, while other compartments of
the kidney are unaffected.
Expression of RSOR protein in embryonic and
neonatal kidneys
A polyclonal anti-RSOR antibody was used, and its
generation and specificity has been described previously
[21]. To assess the expression in metanephroi exposed
to high glucose ambience and immunoprecipitation ex-
periments were carried out. Day E15 embryonic kidneys
were used since metanephroi prior to this time point of
development has very little protein expression. The ex-
plants were radiolabeled with [35S]-methionine, protein
extracted, and the extracts were utilized for the immuno-
precipitation using anti-RSOR antibody. The SDS-PAGE
autoradiogram of immunoprecipitated metanephric pro-
teins revealed a major ∼32 kD band (Fig. 4A, lane 1,
double-headed arrow). This ∼32 kD band is of simi-
lar size as that of the recombinant protein minus the
deeper cortex (E), and a mild reduction is seen in kidneys of the fetuses
of diabetic mothers (F). At day E19 or newborn kidneys, the RSOR
expression is relatively increased compared to day E17 and is confined
to the subcortical tubules (G and I). The RSOR expression is seen in
the entire thickness of the renal cortex in the kidneys harvested from
fetuses of diabetic mothers (H and J, double-headed arrow). At 1 week,
RSOR expression is confined to the tubules of the entire width of the
cortex (K), and a marked increase is seen in the hyperglycemic mice
(L). No expression is seen in the medulla (M).
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Fig. 4. Various analyses. (A) Immunoprecipitation analyses of de novo synthesized renal-specific oxidoreductase (RSOR) in day E15 explants
treated with various concentrations (5 to 30 mmol/L) of D-glucose and radiolabeled with [35S]-methionine. Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) autoradiogram of the immunoprecipitated metanephric proteins reveals a major ∼32 kD band (double-headed
arrow). The intensity of the band decreases in explants treated with 20 mmol/L or 30 mmol/L D-glucose. (B and C) Western blot analyses of RSOR
protein in kidneys harvested from newborn and 1-week-old normoglycemic/hyperglycemic mice. Similar to the immunoprecipitation, a ∼32 kD
band (double-headed arrow) is seen in the newborn kidneys of nondiabetic mice, and its intensity increases in proportion to the elevation of blood
glucose levels.
∼4 kD c-myc-(His)6 tag. The intensity of the band de-
creased in the immunoprecipitated proteins isolated from
metanephric explants treated with 20 mmol/L or 30
mmol/L D-glucose (Fig. 4A, lanes 2 and 3), suggesting a
dose-dependent down-regulated expression of de novo
synthesized RSOR under high glucose ambience. The
protein expression in kidneys of newborn and 1-week-
old mice was assessed by Western blot analyses since
by that time expression is relatively well-established in
the kidneys. Similar to the immunoprecipitation results,
a ∼32 kD band (Fig. 4B, lane 1, double-headed arrow)
was seen in the newborn kidneys of nondiabetic mice. The
intensity of this band increased in mice with elevated glu-
cose levels (Fig. 4B, lanes 2 and 3, double-headed arrow),
suggesting an increased expression of RSOR in high glu-
cose ambience. Occasionally, a faint band of ∼30 kD was
seen which may be a degradation product. At 1 week, the
intensity of the ∼32 kD band increased in proportional
to the elevated concentrations of glucose in the blood
(Fig. 4C, lanes 1 to 3, double-headed arrow). A few very
faint high molecular bands were also seen, which may be
due to aggregation of the RSOR protein. The intensity of
the bands in animals with blood glucose above 300 mg/dL
were remarkably accentuated in kidneys of both newborn
and 1-week-old mice, suggesting that high glucose has an
effect on the expression of this enzyme.
Spatiotemporal protein expression of RSOR in fetal and
neonatal kidneys
By immunofluorescence microscopy the RSOR
expression was seen in the epithelial elements of the
explant and not in the metanephric mesenchyme. At day
E13, the ureteric bud branches exhibited a notable de-
gree of immunoreactivity with the anti-RSOR antibody
(Fig. 5A). With the treatment of 30 mmol/L D-glucose,
a decrease in the immunoreactivity was observed in
metanephros, which, as expected, was reduced in size as
well along with the blunting of the tips of ureteric bud
branches (Fig. 5B, arrowheads). At day E15, the RSOR
was also localized to the ureteric bud branches with slight
increase in its immunoreactivity (Fig. 5C). Interestingly,
unlike the gene expression, the protein was also local-
ized to immature scattered tubular segments. With high
glucose treatment, the size of the explants was slightly
reduced, and the RSOR immunoreactivity lessened both
in the ureteric bud branches as well as in the tubular
segments (Fig. 5D). The RSOR expression by day E17
kidneys got localized to the tubules in the deeper portion
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Fig. 5. Spatiotemporal renal-specific oxidoreductase (RSOR) protein
expression, as assessed by immunofluorescence microscopy. At day E13,
the RSOR expression is seen in the ureteric bud branches (U) (A). With
the treatment of 30 mmol/L D-glucose, a decrease in the immunoreac-
tivity is observed with flattening of the tips of ureteric bud branches
(B, arrowheads). At day E15, the expression is localized to the ureteric
bud branches and immature scattered tubular segments (C), and it is
reduced under high glucose ambience (D). At day E17, the RSOR
expression is localized to the tubules of the deeper renal cortex (E), and
it is reduced in day E17 metanephroi harvested from mouse fetuses of
hyperglycemic mothers (F). In the newborn, RSOR immunoreactivity
is localized to the subcortical tubules (G and I), and its expression is
Fig. 6. Apoptosis in embryonic and neonatal kidneys subjected to high
glucose ambience. By light microscopy, a dose-dependent decrease in
the size of the day E13 explants is observed with varying concentrations
of D-glucose (5 mm to 30 mmol/L) along with deformation of ureteric
bud branches (U) (B vs. D and F). The extent of apoptosis was assessed
by terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuri-
dine triphosphate (dUTP) nick-end labeling (TUNEL) assay. A dose-
dependent increase in the apoptosis was seen in day E13 metanephroi
treated with high D-glucose (A vs. C and E, arrowheads). A basal de-
gree of apoptosis is also seen in the peripheral nephrogenic zone of
metanephroi exposed to 5 mmol/L D-glucose (A, arrowhead). The kid-
neys harvested from day E19 (newborn) or 1-week-old diabetic mice
show minimal amount of apoptosis, although a mild increase is seen in
the kidneys from diabetic mice (I, arrowheads).
of the renal cortex (Fig. 5E). The expression was reduced
in day E17 metanephroi harvested from mouse fetuses of
diabetic mothers, although no significant reduction in the
overall size of the fetal kidneys was observed (Fig. 5F).
In the newborn, like the gene expression the RSOR im-
munoreactivity was localized to the subcortical tubules
(Fig. 5G), and it could be clearly visualized at a higher
seen spanning the entire width of the cortex (H and J, double arrow-
head) in hyperglycemic animals. At 1 week, the expression is seen con-
fined to the entire cortex (K), and RSOR immunoreactivity increases
in the cortex with focal extension into the medullary tubules (L). No
expression is seen in the deeper medulla (M) or glomeruli.
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magnification (Fig. 5I). The expression spread toward
the periphery in kidneys of newborn diabetic mice, and
it was observed spanning the entire width of the cortex
(Fig. 5H and J, double arrowhead). By 1 week of postnatal
life, the RSOR protein expression was seen confined to
the entire cortex (Fig. 5K, double arrowhead); however,
no expression was seen in the medulla and glomeruli. In
the diabetic mice, besides an increase in the immunoreac-
tivity of the cortex and focal extension into the medullary
tubules and increase in the size of the kidney, expression
in the glomerular compartment remained entirely absent
(Fig. 5L).
Apoptosis in embryonic and neonatal kidneys subjected
to high glucose ambience
By light microscopy of EPON-embedded thick sec-
tions, a dose-dependent decrease in the size of the day
E13 metanephroi was observed with varying concentra-
tions of D-glucose (5 mmol/L to 30 mmol/L) (Fig. 6B,
D, and F). The details of such changes which included
a decrease in the size, reduction in the population of
tubules and glomeruli, and deformities of the ureteric bud
branches have been described in a previous publication
[31], and thus are not included here. At high magnification
of thick sections, one could observe condensed pyknotic
nuclei, reminiscent of apoptotic bodies, throughout the
metanephros. To validate the extent of apoptosis TUNEL
assay was performed. The apoptosis was dose-dependent,
and it was readily visualized in day E13 metanephroi
treated with 30 mmol/L D-glucose (Fig. 6C and E, arrow-
heads). Certainly, a basal degree of apoptosis was also
seen in the peripheral nephrogenic zone of metanephroi
exposed to 5 mmol/L D-glucose (Fig. 6A, arrowhead); on
the other hand, the apoptosis was widespread through-
out the parenchyma of the metanephroi subjected to high
glucose ambience (Fig. 6E, arrowheads). Interestingly, in
kidneys harvested from day E19 (newborn) or 1-week-
old diabetic mice minimal amount of apoptosis was ob-
served, although it was increased from the basal level, as
seen in the control mice with normoglycemia (Fig. 6I vs.
G, arrowheads).
DISCUSSION
The complications seen during embryonic life can be
ascribed as diabetic embryopathy or diabetic fetopathy,
meaning thereby that there is an abnormal development
of the embryo or fetus in a maternal hyperglycemic envi-
ronment. Similar to the diverse complications in adult
life, the development of multiple organ systems is af-
fected during embryonic life, and the malformations
induced are collectively referred to as diabetic embryopa-
thy. The concept of diabetic embryopathy as described
in the older literature includes a two- to fourfold in-
creased incidence of malformations occurring during em-
bryogenesis in offsprings of diabetic mothers between
the third and seventh week (i.e., at the end of blasto-
genesis and beginning of organogenesis) [38–40]. The
diabetic embryopathy may be associated with diabetic
fetopathy, the latter refers to the abnormal development
of the fetus after the tenth week of gestation. Both di-
abetic embryopathy and diabetic fetopathy are induced
by diabetes mellitus in pregnant women; however, the
pathogenetic mechanism(s), the extent of congenital mal-
formations, and the time frame for their development
may be different [41, 42]. The malformations seen in dia-
betic embryopathy are often confined to the central ner-
vous, cardiovascular, gastrointestinal, genitourinary, and
musculoskeletal systems [41, 42]. The malformations of
the musculoskeletal system may include agenesis of lum-
bosacral spine, sirenomelia, or underdevelopment of the
lower extremities associated with major visceral abnor-
malities, and they are collectively referred to as “cau-
dal regression syndrome” [43]. The visceral abnormalities
may include malformation of the genitourinary system,
which can occur in the absence of caudal regression syn-
drome. In line with such observations, the in vitro data
of this investigation indicate that exposure of embryonic
metanephros to high glucose induce marked changes with
ureteric bud branching dysmorphogenesis and reduced
population of nascent nephron, the latter reflecting a de-
crease in both the tubules and glomeruli (Fig. 1). The
decrease in the population of nephron and branching dys-
morphogenesis may be mutually exclusive since interca-
lation of the ureteric bud into the mesenchyme leads to
the formation of nephron, while induced mesenchyme
reciprocally stimulates its dichotomous iterations. A de-
crease in the population of glomeruli with a closely par-
allel reduction in the number of tips of the ureteric bud
branches (Table 1) would be certainly supportive of such a
contention.
The intercalation of the ureteric bud is regarded as
the primary initial step while the phenotypic conversion
of the mesenchyme seems to be a secondary event in
metanephric development [24–26]. Thus, any anatomi-
cal deformity in the ureteric bud branching would be
reflected in the dysmorphogenesis of the embryonic
metanephros and ultimately in the formation of nascent
nephrons. This appears to be the case since exposure to
high glucose ambience resulted in the blunting/flattening
of the tips of ureteric bud branches with failure in normal
growth of the metanephros, phenotypic transformation of
the mesenchyme, and development of nephrons (Figs. 1,
3, and 5). During this mesenchymal-to-epithelial trans-
formation, at times the expression of various molecules
change concomitant with their shift in the spatiotemporal
distribution, as exemplified by various ECM molecules,
where mesenchymal glycoproteins are later replaced by
those derived from epithelial cells [28, 29]. Conceivably,
such a spatiotemporal change may not be only confined
Kanwar et al: Renal development and hyperglycemia 1681
to the ECM molecules but could be seen in other genes,
including proto-oncogenes, transcription factors, and in-
tracellular enzymes. In support of this contention are
the findings of the present study where the RSOR was
found to be localized in the ureteric bud branches that
are precursor of collecting ducts during early stages of
gestation (day E13 to E15), and subsequently (i.e., day
E17 onwards), its expression shifted to the subcortical
tubules that are derived from mesenchyme that had un-
dergone epithelial transformation (Figs. 3 and 5). The
expression in the following time period of neonatal and
postnatal development gets well-established in the sub-
cortical tubules. The shift in the RSOR expression from
medullary to the subcortical tubules may be related to
the continuum of the changes that reflect maturation
of the metanephros where there is constant shift in the
expression of several genes, including ECM molecules,
proto-oncogenes, and various glucose transporters [28].
Interestingly, high glucose differentially modulates the
RSOR expression on the two compartments of the
mammalian kidney (i.e., ureteric bud branches, the pro-
genitor of collecting ducts vs. the subcortical tubules).
The expression in the ureteric bud branches disappears
with the high glucose treatment while it accentuates in
the cortical tubules with extension into the subcapsular
and corticomedullary tubules. These changes, whether in-
crease or decrease in the RSOR expression, were of suffi-
cient magnitude that they were also reflected in the gene
expression by RT-PCR and Northern blot analyses and
protein expression by immunoprecipitation and Western
blot analyses of the whole kidney extracts, that are in-
clusive of other compartments not expressing the RSOR
(Figs. 2 and 4). Nevertheless, the pattern of gene and pro-
tein expression (i.e., decrease during embryonic period
and accentuation in the later and neonatal life) paral-
leled with that observed by spatiotemporal expression
analyses.
Such a differential expression in response to high glu-
cose ambience is intriguing. An apparent possibility that
one can entertain would be the oxidant stress that is well-
recognized to a play a pathogenetic role in the renal
complications of diabetes mellitus, which at times may
be associated with apoptosis of the cells [44]. The oxi-
dant stress is also well-recognized as one of the major
factor in mediating teratogenic effects on the developing
embryo since oral administration of vitamin E or mouse
carrying superoxide dismutase gene ameliorate diabetes-
associated embryopathy [45]. Conceivably, the oxidant
stress in culture conditions may mediate its dysmorpho-
genetic effect either by disrupting the biologic activity of
the morphogenetic regulators (e.g., ECM proteins), or
by inducing apoptosis of the cells that are in transition to
undergone phenotypic transformation (e.g., metanephric
mesenchyme).
The first possibility was explored in our previous publi-
cations where marked decreased de novo synthesis of one
of ECM proteins (i.e., sulfated proteoglycans) was ob-
served under high glucose ambience [31, 46]. Moreover,
as indicated in the introduction section (vide supra) that
oxygen radicals readily disrupt the synthesis of proteogly-
cans [30] that are regarded as the major morphogenetic
modulators among the various ECM glycoproteins stud-
ied so far, as reported by our laboratory more than decade
and half ago [34]. A decrease in the concentration of de
novo synthesized sulfated proteoglycans at the blunted
tips of the ureteric bud branches was seen associated with
poor growth of the embryonic kidney explants in culture.
These observations (i.e., role of proteoglycans in renal
development) have been recently reexamined and con-
firmed by others [47], suggesting that sulfated proteogly-
cans are indeed critical ECM molecules that modulate
the morphogenesis of metanephros.
The second possibility (i.e., apoptosis) was explored
in this investigation, and expectedly, a dose-dependent
fulminant apoptosis was observed in embryonic kidneys
under high glucose ambience (Fig. 6). Interestingly, the
extent of apoptosis like the RSOR expression was differ-
entially modulated in embryonic vs. neonatal or postnatal
tissues. In neonatal or postnatal tissues very little apop-
tosis was observed (Fig. 6). The oxidant stress and apop-
tosis may be regarded as the mutually dependent pro-
cesses, nevertheless, the apoptosis would certainly result
in the developmental arrest of embryonic metanephros
and generation of fewer nascent nephrons and reduced
expression of various molecules, including RSOR, as ob-
served in this investigation (Figs. 2 and 5). One may pos-
tulate that RSOR was unaffected or in fact up-regulated
during neonatal or postnatal life may be due to the fact
that very little apoptosis was observed. Alternatively, the
oxidant stress effects may be independent of the process
of apoptosis, since apoptosis is not often observed in adult
animals with diabetic nephropathy or any other scleros-
ing nephritides in vivo [48].
Other renal lesions in which RSOR expression seems
to be modulated include acute renal failure (ARF) in rat
which was reported in the literature a few years back
[49]. In that study, another kidney-specific protein (KSP)
with a molecular mass of ∼32 kD, thus known as KSP32,
was identified. The KSP32, isolated from rat and human,
exhibits more than 95% homology with mouse RSOR;
however, the critical AKR-3 motif (MAKS/IPKS) that
binds to the NADPH is lacking. The KSP32 has identi-
cal spatiotemporal distribution in the proximal and dis-
tal tubules of the renal cortex as that of RSOR. In the
model of acute ischemic renal injury, the KSP32 has
been reported to be down-regulated, and that is reflected
in both gene and protein expression [49]. Interestingly,
ARF due to ischemia is known to be associated with cell
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death, necrosis, and apoptosis [50, 51]. This would sup-
port the findings of the present study where RSOR down-
regulation with concomitant dose-dependent fulminant
apoptosis was observed in the embryonic metanephros
(Fig. 6), suggesting that the expression of RSOR/KSP32
parallels the extent of apoptosis in other renal lesions be-
sides those induced by high glucose ambience. Since there
seems to be a certain degree of correlation between the
RSOR/KSP32 expression and extent of apoptosis, one
may speculate that this enzyme has an antiapoptotic ef-
fect. However, at present there is no data in literature
to support this contention. To address this issue further
cell culture studies are needed where one can assess the
effect of under- or overexpression of RSOR/KSP32 on
apoptosis in a high glucose ambience.
Recently, a porcine homologue of mouse RSOR that
is linked to glucose metabolism has been described and
is referred to as myo-inositol oxygenase (MIOX) [52].
The MIOX oxidizes myo-inositol to yield D-glucuronic
acid; however, like KSP32, it also lacks NADPH bind-
ing site seen in the RSOR. Nevertheless, MIOX certainly
has a tremendous significance since perturbation in the
myo-inositol has been well-documented in the literature
in relation to glucose metabolism [18, 53, 54]. Glucose
has been shown to inhibit the cellular uptake of myo-
inositol by the glomerular cells [53], thereby causing its
increased urinary excretion along with that of D-chiro-
inositol, an isomer of myo-inositol [54]. Ultimately de-
ficiency of myo-inositol occurs in various tissues, which
upon its supplementation reverses some of the glucose-
induced perturbed functions, including cell proliferation
and procollagen expression and secretion [18]. Inter-
estingly, myo-inositol deficiency has been described to
be associated with developmental embryonic abnormal-
ities, such as, spina bifida [55], suggesting that glucose-
induced dysmorphogenesis may also be related to the
disturbances in the myo-inositol metabolism. It is con-
ceivable, that increased activity of MIOX may contribute
to the myo-inositol deficiency in various tissues in dia-
betic state; however, the precise mechanism(s) remains
to be worked out. Along these lines, the mechanisms by
which high glucose ambience induces increased expres-
sion of MIOX/RSOR/KSP32 would be the subject matter
of future investigations.
CONCLUSION
This communication describes a biphasic expression of
a glucose-responsive enzyme, RSOR, during embryonic
vs. neonatal/postnatal periods, and its expression paral-
lels to the extent of apoptosis that is reflective of the ox-
idant stress usually seen under high glucose ambience. It
is anticipated that the findings of this investigation would
give certain impetus for further studies to explore the
yet not fully understood pathogenetic mechanisms relat-
ing to diabetic nephropathy that are pertinent to tubular
pathobiology.
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